PT  - JOURNAL ARTICLE
AU  - M. A. Bookman
AU  - B. E. Greer
AU  - R. F. Ozols
TI  - Optimal therapy of advanced ovarian cancer: carboplatin and paclitaxel versus cisplatin and paclitaxel (GOG158) and an update on GOG0182-ICON5
AID  - 10.1136/ijgc-00009577-200311001-00004
DP  - 2003 Oct 01
TA  - International Journal of Gynecologic Cancer
PG  - 149--155
VI  - 13
IP  - Suppl 2
4099  - http://ijgc.bmj.com/content/13/Suppl_2/149.short
4100  - http://ijgc.bmj.com/content/13/Suppl_2/149.full
SO  - Int J Gynecol Cancer2003 Oct 01; 13
AB  - Mature results from GOG158 have clearly established carboplatin and paclitaxel as an effective and well-tolerated standard regimen, providing a basis for the reference arm in GOG0182-ICON5, an ongoing multiarmed phase III trial of the Gynecologic Cancer InterGroup (GCIG) evaluating the incorporation of newer cytotoxic agents. Results from GOG158 will be reviewed, including an analysis of second-look surgical outcomes, followed by an update on the current status of GOG0182-ICON5.